Security Name | Ticker | % of Net Assets |
---|---|---|
ABBVIE INC | ABBV | 8.22% |
AMGEN INC. | AMGN | 5.29% |
GILEAD SCIENCES, INC. | GILD | 4.93% |
VERTEX PHARMACEUTICALS | VRTX | 4.23% |
ALNYLAM PHARMACEUTICALS | ALNY | 3.32% |
REGENERON PHARMACEUTICALS | REGN | 3.13% |
INSMED INC | INSM | 2.56% |
CORTEVA INC | CTVA | 2.41% |
ASTRAZENECA PLC ADR | AZN | 2.11% |
NATERA INC | NTRA | 2.02% |
BEONE MEDICINES LTD-ADR | BGNE | 1.80% |
BIOGEN IDEC, INC. | BIIB | 1.80% |
ROYALTY PHARMA PLC- CL A | RPRX | 1.73% |
INCYTE CORP | INCY | 1.56% |
ILLUMINA INC | ILMN | 1.51% |
IONIS PHARMACEUTICALS, IN | IONS | 1.48% |
NEUROCRINE BIOSCIENCES IN | NBIX | 1.47% |
EXACT SCIENCES | EXAS | 1.44% |
ARGENX SE - ADR | ARGX | 1.42% |
VIATRIS INC | VTRS | 1.42% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 1.35% |
UNITED THERAPEUTICS CORP | UTHR | 1.34% |
EXELIXIS, INC. | EXEL | 1.29% |
BRIDGEBIO PHARMA INC | BBIO | 1.29% |
CRISPR THERAPEUTICS AG | CRSP | 1.28% |
MODERNA INC | MRNA | 1.28% |
GUARDANT HEALTH INC | GH | 1.28% |
BIOMARIN PHARMACEUTICAL | BMRN | 1.26% |
ROIVANT SCIENCES LTD | ROIV | 1.19% |
ALKERMES PLC | ALKS | 1.18% |
REVOLUTION MEDICINES INC | RVMD | 1.17% |
AVIDITY BIOSCIENCES INC | RNA | 1.17% |
CYTOKINETICS INC | CYTK | 1.13% |
VAXCYTE INC | PCVX | 1.10% |
BIONTECH SE-ADR | BNTX | 1.08% |
ARROWHEAD PHARMACEUTICALS | ARWR | 1.06% |
HALOZYME THERAPEUTICS INC | HALO | 1.05% |
PROTAGONIST THER | PTGX | 0.99% |
INTELLIA THERAPE | NTLA | 0.98% |
LEGEND BIOTECH CORP-ADR | LEGN | 0.98% |
PTC THERAPEUTICS | PTCT | 0.97% |
TG THERAPEUTICS | TGTX | 0.95% |
VIKING THERAPEUTICS INC | VKTX | 0.94% |
AXSOME THERAPEUT | AXSM | 0.93% |
CRINETICS PHARMACEUTICALS | CRNX | 0.93% |
AKERO THERAPEUTICS INC | AKRO | 0.90% |
NUVALENT INC-A | NUVL | 0.87% |
ULTRAGENYX PHARM | RARE | 0.76% |
MEDPACE HOLDINGS | MEDP | 0.74% |
RECURSION PHARMACEUTICALS | RXRX | 0.73% |
VERACYTE INC | VCYT | 0.72% |
ADMA BIOLOGICS INC | ADMA | 0.71% |
SUMMIT THERAPEUTICS INC | SMMT | 0.70% |
SAREPTA THERAPEU | SRPT | 0.68% |
DYNE THERAPEUTICS INC | DYN | 0.67% |
ARCELLX INC | ACLX | 0.66% |
BEAM THERAPEUTICS INC | BEAM | 0.66% |
IDEAYA BIOSCIENCES INC | IDYA | 0.66% |
APELLIS PHARMACE | APLS | 0.66% |
AMICUS THERAPEUTICS INC | FOLD | 0.65% |
ACADIA PHARMACEUTICALS IN | ACAD | 0.61% |
AGIOS PHARMACEUT | AGIO | 0.61% |
DENALI THERAPEUT | DNLI | 0.61% |
TWIST BIOSCIENCE CORP | TWST | 0.59% |
CELLDEX THERAPEUTICS INC | CLDX | 0.56% |
MADRIGAL PHARMAC | MDGL | 0.53% |
ASCENDIS PHA-ADR | ASND | 0.53% |
SOLENO THERAPEUTICS INC | SLNO | 0.51% |
NOVAVAX INC | NVAX | 0.47% |
IMMUNOVANT INC | IMVT | 0.46% |
KRYSTAL BIOTECH INC | KRYS | 0.46% |
DYNAVAX TECHNOLOGY | DVAX | 0.44% |
IOVANCE BIOTHERAPEUTICS | IOVA | 0.20% |
Other (Cash, derivatives and other liabilities) | 0.63% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.